Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Revision: v3.3.2 is now displayed, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-28T00:31:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added the labels 'Last Update Posted (Estimated)' and 'Revision: v3.3.1', and removed 'Last Update Posted' and 'Revision: v3.2.0'; this is a minor UI/versioning update that does not modify the study data or participation details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-20T22:29:19.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new trial site was added: Tainan, Taiwan, 704, with a Last Update Posted entry on 2025-11-06. The prior listing for Tainan City, Taiwan, 704 was removed on 2025-10-28.
    Difference
    0.2%
    Check dated 2025-11-13T16:52:10.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Recent changes appear to be updates to study record dates (e.g., 2025-10-28, 2025-10-09, 2025-10) and do not alter core content such as design, eligibility, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:14:52.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Updated the site version from v3.0.2 to v3.2.0; this is a metadata/versioning change with no other content changes.
    Difference
    0.0%
    Check dated 2025-10-01T03:55:49.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Updated version 3.0.2 metadata: new dates (2025-09-15, 2025-09-11, 2025-09), new location strings (México, Mexico, 03100 and 14080), and updated label (Last Update Posted (Estimated)); removed older dates and revision 3.0.1 and the Back to Top item.
    Difference
    0.5%
    Check dated 2025-09-16T19:47:01.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.